Author: Polaryx Therapeutics, Inc.

Posted Date:

February 3, 2026

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

Polaryx Therapeutics, Inc.

February 3, 2026
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”

Polaryx Therapeutics, Inc.

February 2, 2026
Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq

Polaryx Therapeutics, Inc.

January 30, 2026